An older patient with unilateral vision loss, headaches, fatigue, proximal weakness, and an elevated ESR. What is the recommended treatment?

Study for the NBME Form 13 Test with our comprehensive quiz collection, featuring flashcards and multiple-choice questions to ensure your readiness. Enhance your knowledge with detailed explanations for each question.

Multiple Choice

An older patient with unilateral vision loss, headaches, fatigue, proximal weakness, and an elevated ESR. What is the recommended treatment?

Explanation:
This presentation points to giant cell arteritis, a vasculitis in adults over 50 that can threaten vision. The priority is to prevent irreversible blindness from ischemia of the optic nerve, so treatment must start immediately with high-dose glucocorticoids. The best choice is prednisone at a high dose (about 40–60 mg daily). If there’s acute vision loss, many clinicians begin with intravenous methylprednisolone (1 g daily for 3 days) followed by oral prednisone and a gradual taper. Temporal artery biopsy should be pursued to confirm the diagnosis, but treatment should not wait for biopsy results. The other agents listed are not first-line for suspected giant cell arteritis with vision risk; they’re typically used as steroid-sparing options or for different vasculitides, not to provide the urgent vessel-wide anti-inflammatory effect needed here.

This presentation points to giant cell arteritis, a vasculitis in adults over 50 that can threaten vision. The priority is to prevent irreversible blindness from ischemia of the optic nerve, so treatment must start immediately with high-dose glucocorticoids. The best choice is prednisone at a high dose (about 40–60 mg daily). If there’s acute vision loss, many clinicians begin with intravenous methylprednisolone (1 g daily for 3 days) followed by oral prednisone and a gradual taper. Temporal artery biopsy should be pursued to confirm the diagnosis, but treatment should not wait for biopsy results.

The other agents listed are not first-line for suspected giant cell arteritis with vision risk; they’re typically used as steroid-sparing options or for different vasculitides, not to provide the urgent vessel-wide anti-inflammatory effect needed here.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy